Skip to main content

Closed

NXTC: NextCure, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-174.6%

Financially safe

Stretched

Debt / equity0.18×

Interest coverage0.0×

Current ratio4.61×

NextCure, Inc.

NXTCNASDAQ Global Select·USD·Closed

NextCure, Inc.

NXTCNASDAQ·USD·Closed

$4.14

−17.59%

$4.14

−$0.89 (17.59%)

52W Range

18thpctl

Volume

0.18×avg

Mkt Cap

14.97MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

18thpctl

Volume

0.18×avg

Market Cap

14.97MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings